Thanks cityslicker.

I didn't mean to mislead on the trial location. At slide 8 during the AGM Don said "We’ve also in this short period of time confirmed principal investigators. We have pending ethics approval reviews at various hospitals in Ontario, Alberta and Quebec." So this is what I expected to see in clinicaltrials.gov.

The reason I mentioned San Francisco is that was listed in clinicaltrials.gov under location when I did the search. I think that is because Mike Sweeney is SF based but I don't know if that is the reason.

My naive hope is that the ethics committee reviews take into account the Cell research paper and the 2 other papers and perhaps the well established safety profile and BTD of apabetalone and they accelerate the apabetalone trial because of the new strain and growing cases.

GLTA

Toinv